Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DKS Co. Ltd., formerly known as Dai-Ichi Kogyo Seiyaku, is a Japanese chemical company with a significant presence in the life sciences and healthcare sectors. The company specializes in the production of high-quality pharmaceutical excipients, including povidone (PVP) and sucrose fatty acid esters, which are essential for drug formulation and delivery. Beyond excipients, DKS is a major producer of functional lipids such as DHA and EPA, catering to the nutritional and pharmaceutical markets. With over a century of expertise in surfactant and polymer chemistry, DKS provides critical materials that enhance the stability and efficacy of various healthcare products. The company operates globally, leveraging its advanced manufacturing capabilities to serve the pharmaceutical, food, and industrial sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DKS.